<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03049514</url>
  </required_header>
  <id_info>
    <org_study_id>MOA_2016_22</org_study_id>
    <nct_id>NCT03049514</nct_id>
  </id_info>
  <brief_title>Study of Arterial Recanalization of the Central Retinal Artery Occlusions</brief_title>
  <acronym>RECANAL</acronym>
  <official_title>Study of Arterial Recanalization of the Central Retinal Artery Occlusions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Central retinal artery occlusions (CRAO) are the equivalent of an ischemic stroke (IS) at the
      retinal level. They share the same risk factors and common pathology. Their incidence is
      lower (8.5 / 100,000) and the functional prognosis is unfavorable in 80% of cases with visual
      acuity (VA) &lt;1/10. The diagnosis of an CRAO is clinically based on the sudden occurrence of a
      decrease in deep visual acuity with fundamentally signs of reactive ischemia. There is no
      data on early retinal arterial recanalization after CRAO, nor on the relationship between
      early recanalization (spontaneous or post-thrombolysis) and visual prognosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 23, 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dynamic retinal angiography data at 24 hours (+/- 24 hours)</measure>
    <time_frame>24 hours (+/- 24 hours) following the beginning of symptoms</time_frame>
    <description>Proportion of patients with early arterial recanalization.The recanalization rate will be compared between thrombolysed patients and non-thrombolysed patients</description>
  </primary_outcome>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Central Retinal Artery Occlusion</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred for an central retinal artery occlusion
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Central Retinal Artery Occlusion ≤ 24 hours

        Exclusion Criteria:

          -  Retinal Dynamic angiography not performed within 48 hours of onset of symptoms

          -  Occlusion of a branch of the central retinal artery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michaël Obadia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation A de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence Salomon, MD, PhD</last_name>
    <phone>+33 148 036 431</phone>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondation ophtalmique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence Salomon, MD, PhD</last_name>
      <phone>+33 1 48 03 64 31</phone>
      <email>lsalomon@for.paris</email>
    </contact>
    <contact_backup>
      <last_name>Michaël Obadia, MD</last_name>
      <email>mobadia@for.paris</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2017</study_first_submitted>
  <study_first_submitted_qc>February 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2017</study_first_posted>
  <last_update_submitted>February 8, 2017</last_update_submitted>
  <last_update_submitted_qc>February 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Thrombolysis</keyword>
  <keyword>Recanalization</keyword>
  <keyword>Dynamic retinal angiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Retinal Artery Occlusion</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

